Istvan Kenessey, Ph.D.
Affiliations: | 2010 | Semmelweis Egyetem, Hungary |
Area:
Molecular Biology, PathologyGoogle:
"Istvan Kenessey"Parents
Sign in to add mentor| Jozsef Tovari | grad student | 2010 | Semmelweis Egyetem | |
| (A motogen szignal vizsgalata human melanomasejtekben.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cserepes M, Nelhűbel GA, Meilinger-Dobra M, et al. (2022) EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer. Cancers. 14 |
| Nelhűbel GA, Cserepes M, Szabó B, et al. (2021) EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas. Pathology Oncology Research : Por. 27: 620256 |
| Cserepes M, Nelhűbel GA, Meilinger-Dobra M, et al. (2021) [Consequences of extracellular alterations of EGFR on cetuximab therapy in HNSCC]. Magyar Onkologia. 65: 188-195 |
| Uhlyarik A, Piurko V, Papai Z, et al. (2020) EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy. Cancers. 12 |
| Uhlyarik A, Piurko V, Vizkeleti L, et al. (2019) EGFR Protein Expression of KRAS Wild-Type Colorectal Cancer: Predictive Value of the Sidedness for Efficacy of Anti-EGFR Therapy. Pathology Oncology Research : Por |
| Imrédi E, Liszkay G, Kenessey I, et al. (2018) Aquaporin-1 Protein Expression of the Primary Tumor May Predict Cerebral Progression of Cutaneous Melanoma. Pathology Oncology Research : Por |
| Kenessey I, Kramer Z, István L, et al. (2018) Inhibition of epidermal growth factor receptor improves antitumor efficacy of vemurafenib in BRAF-mutant human melanoma in preclinical model. Melanoma Research |
| Timar J, Piurko V, Kenessey I, et al. (2018) EGFR protein expression of the metastatic colorectal cancer as a prognostic/predictive factor for anti-EGFR antibody therapy. Journal of Clinical Oncology. 36 |
| Hegedüs L, Padányi R, Molnár J, et al. (2017) Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca(2+) Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK. Frontiers in Oncology. 7: 95 |
| Tátrai E, Bartal A, Gacs A, et al. (2017) Cell type-dependent HIF1 α-mediated effects of hypoxia on proliferation, migration and metastatic potential of human tumor cells. Oncotarget |